Friday, August 14, 2020
News
NEWS HOME
»
PRESS RELEASES

New AMR Action Fund steps in to save collapsing antibiotic pipeline with pharmaceutical industry investment of US$1 billion
  SocialTwist Tell-a-Friend  
   


Date: 10-07-2020 10:13AM
Source: IFPMA
Category: General, Science & Research, Banking & Financial Services, Healthcare & Biotechnology, Pharmaceutical, Philanthropy
Location: Geneva, Switzerland

Business Wire India

Today, more than 20 leading biopharmaceutical companies announced the launch of the AMR Action Fund [www.AMRactionfund.com], a ground-breaking partnership that aims to bring 2-4 new antibiotics to patients by 2030. These treatments are urgently needed to address the rapid rise of antibiotic-resistant infections – also called antimicrobial resistance, or AMR. The companies have raised so far nearly US$1 billion new funding to support clinical research of innovative new antibiotics that are addressing the most resistant bacteria and life-threatening infections. Through the AMR Action Fund, pharmaceutical companies will join forces with philanthropies, development banks, and multilateral organizations to strengthen and accelerate antibiotic development. The Fund will focus on urgent public health needs. It will provide much needed financial resources, as well as important technical support to help biotech companies bring novel antibiotics to patients.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200709005154/en/

The AMR Action Fund, an initiative of the international body representing the R&D pharmaceutical industry (International Federation of Pharmaceutical Manufacturers & Associations, IFPMA), was announced at simultaneous virtual launch events in Berlin, Germany, and Washington, D.C., USA, with a third event in Tokyo, Japan taking place on July 10.

AMR is a looming global crisis that has the potential to dwarf COVID-19 in terms of deaths and economic costs. While tragically the death toll of COVID-19 continues to rise, each year 700,000 people are dying from AMR. In some of the most alarming scenarios, it is estimated that by 2050 AMR could claim as many as 10 million lives per year.

“Unlike COVID-19, AMR is a predictable and preventable crisis. We must act together to rebuild the pipeline and ensure that the most promising and innovative antibiotics make it from the lab to patients,” said Thomas Cueni, Director General of the IFPMA, one of the organizers of the new fund. He adds: “The AMR Action Fund is one of the largest and most ambitious collaborative initiatives ever undertaken by the pharmaceutical industry to respond to a global public health threat”.

The world urgently needs new antibiotics, but there are few in the pipeline because of a paradox: despite the huge societal costs of AMR, there is currently no viable market for new antibiotics. New antibiotics are used sparingly to preserve effectiveness, so in recent years, a number of antibiotic-focused biotechs have declared bankruptcy or exited this space due to the lack of commercial sustainability, resulting in the loss of valuable expertise and resources. The consequence is a huge public health need for new antibiotics, but a lack of funding available for antibiotic R&D, particularly the later stages of clinical research. This creates a “valley of death” between discovery and patient access.

“With the AMR Action Fund, the pharmaceutical industry is investing nearly US$1 billion to sustain an antibiotic pipeline that is on the verge of collapse, a potentially devastating situation that could affect millions of people around the world,” said David Ricks, Chairman and CEO of Eli Lilly and Company and President of IFPMA. “The AMR Action Fund will support innovative antibiotic candidates through the most challenging later stages of drug development, ultimately providing governments time to make the necessary policy reforms to enable a sustainable antibiotic pipeline.”

While the AMR Action Fund is an important step in addressing the challenge of AMR, policymakers across the globe must enact market-based reforms, including reimbursement reform and new pull incentives, to revitalize the antibiotics market and drive sustainable investments in antibiotic R&D. Until then, the biopharmaceutical industry is taking action now to support the current pipeline of antibiotics.

With this investment from leading biopharmaceutical companies, the AMR Action Fund will be the largest collective venture ever created to address AMR. The AMR Action Fund will:

  • Invest in smaller biotech companies focused on developing innovative antibacterial treatments that address the highest priority public health needs, make a significant difference in clinical practice, and save lives.
  • Provide technical support to portfolio companies, giving them access to the deep expertise and resources of large biopharmaceutical companies, to strengthen antibiotic development, and support access and appropriate use of antibiotics.
  • Bring together a broad alliance of industry and non-industry stakeholders, including philanthropies, development banks, and multilateral organizations, and help encourage governments to create market conditions that enable sustainable investment in the antibiotic pipeline.

The AMR Action Fund expects to invest more than US$1 billion with the support of future partners into a portfolio of companies to address the funding gap for the financing of antibiotic development. The Fund is expected to be operational during the fourth quarter of 2020.

For more details on the AMR Action fund, visit www.AMRactionfund.com.

Messages of support for the AMR Action Fund

“AMR is a slow tsunami that threatens to undo a century of medical progress. I very much welcome this new engagement of the private sector in the development of urgently-needed antibacterial treatments. WHO looks forward to working with the AMR Action Fund to accelerate research to address this public health crisis.”Dr Tedros Adhanom Ghebreyesus, Director General World Health Organization

“EIB is actively supporting identified market failures with innovative financial instruments, antimicrobial resistance is clearly one. We welcome the opportunity to join forces with public and private actors, such as the pharmaceutical industry, philanthropic funders, multilateral development banks, and the World Health Organization to tackle this threat. The initiative is aligned with the EIB’s core objectives in health and we are proud to be part of the origination group of the new AMR Action Fund.”Werner Hoyer, President, EIB (European Investment Bank)

Biopharmaceutical companies and foundations supporting the AMR Action Fund

Almirall, Amgen, Bayer, Boehringer Ingelheim, Chugai, Daiichi Sankyo, Eisai, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, LEO Pharma, Lundbeck, Menarini, Merck, MSD, Novartis, Novo Nordisk, Novo Nordisk Foundation, Pfizer, Roche, Shionogi, Takeda, Teva, UCB

About AMR Action Fund

The AMR Action Fund is an initiative from over 20 leading biopharmaceutical companies that have pledged to invest nearly US$1 billion, with the aim to bring 2-4 new antibiotics to market by 2030. The AMR Action Fund will invest in small companies developing innovative antibacterial treatments. It will forge partnerships with institutions and philanthropic organizations, development banks, and multilateral organizations to strengthen and accelerate antibiotic development. It will also work with governments to ensure there is a sustainable pipeline of new antibiotics to fight superbugs.

The concept of the AMR Action Fund was developed by the IFPMA and the Biopharmaceutical CEOs Roundtable (BCR), and biopharmaceutical companies and foundation, in collaboration with the World Health Organization (WHO), The European Investment Bank (EIB), and the Wellcome Trust.



CONTACTS :

Abigail Jones, Communications Director, IFPMA
a.jones@ifpma.org
+32 475 41 09 76

Silas Holland, Interim Director of External Affairs, AMR Action Fund
silas.holland@amractionfund.com
+1 202 329 0936

More Press Releases

Mindteck Reports Financial Results for Q1 2020-21

Flex Releases 2020 Sustainability Report

FSS Launches Embark to Digitally Strengthen India’s MSME Segment

High School Internships Made Possible, by Industry Pioneer Alacrous

Hyundai Mobility Membership India’s First Smart Ownership and Lifestyle Experience

NoPaperForms Marks Three Years with ESOP Announcement Worth over USD2 Million

Kent RO Salutes the Real Heroes

Lattice Sentry Solutions Stack and SupplyGuard Service Deliver End-to-End Supply Chain Protection with Dynamic Trust

Lenovo Delivers Outstanding Q1 Performance and Strong Growth, Overcoming Challenging Global Environment

Federal Bank Chooses Fiserv to Support Launch of Their First Independent Credit Card

Velodyne Lidar Powering Intelligent Traffic Management in Nevada

Premier Philippines Airport Enhances Passenger Throughput and Experience with Smiths Detection

Win a Tablet with WorldRemit’s Back to School Competition!

Phase III InPedILD™ trial enrolls first patient to evaluate nintedanib in pediatric population with fibrosing interstitial lung disease

Thales Expands Technology Partner Ecosystem to Accelerate Enterprises’ Cloud and Digital Transformation Initiatives

Moody’s Analytics Three-Peats in Two Categories at Risk Technology Awards

Visa Selects Payswiff as Winner of Visa Everywhere Initiative 2020 in India

AskSarkar - Pakki Jankari Powered by CoRover Among the Winners of Aatma Nirbhar App Innovation Challenge

P97 Networks to Drive Mobile Commerce For ExxonMobil Affiliate Across Its New Zealand Retail Network

Dell Technologies and NITI Aayog’s Atal Innovation Mission Launch Second Student Entrepreneurship Program

Andersen Global Enhances Africa Platform With the Addition of Law Firm in Gabon

Moody’s Acquires Stake in MARC, Strengthening Presence in Key ASEAN Market

Uniphore’s Conversational Service Automation Platform to be Leveraged for WNS’ EXPIRIUS

eMedicoz App Wins Special Mention in PM Modi's #AatmaNirbharApp Innovation Challenge

Immervision Introduces Wide-Angle Distortion Correction Algorithms with Face and Body Protection for Videos on Smartphones

Flow Based Lending - A Door to New Possibilities: LoanTap

 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
DIG holds video conference to assess COV...
Mizoram's COVID-19 tally at 657...
Strict surveillance in Guwahati ahead of...
Rains likely to lash Delhi-NCR in next f...
Security beefed up in Delhi-NCR ahead of...
UP Vidhan Bhawan decked up for I-Day cel...
More...    
 
 Top Stories
Researchers develop cell injection ... 
Total amount sanctioned under Natio... 
SC adjourns for next week hearing o... 
Seeing Vasundhara Raje in green sar... 
Disha Salian's father files police ... 
Rouhani inaugurates big agricultura... 
Ishaan Khatter to star in a war act... 
Netflix releases official trailer o...